EMEA (Europe, Middle East and Africa) Primary Antibodies Market Report 2017

October 2017 | 115 pages | ID: E6B8798E469WEN
QYResearch

Abstracts

In this report, the EMEA Primary Antibodies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Primary Antibodies for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Primary Antibodies market competition by top manufacturers/players, with Primary Antibodies sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Abcam
• BD
• Santa Cruz Biotechnology
• Sigma Aldrich Corporation
• Thermo Fisher Scientific
• Bio-Rad
• R&D Systems
• MBL
• CST
• Merk
• Novus Biologicals
• PeproTech
• Cayman
• AbMax Biotechnology
• MABTech
• KPL
• Abnova

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Human
• Animal

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Primary Antibodies for each application, including

• ELISA
• Western Blot
• Immunostaining
• Immunohistochemistry
• Immunocytochemistry
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Primary Antibodies Market Report 2017

1 PRIMARY ANTIBODIES OVERVIEW

1.1 Product Overview and Scope of Primary Antibodies
1.2 Classification of Primary Antibodies
  1.2.1 EMEA Primary Antibodies Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Primary Antibodies Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Human
  1.2.4 Animal
1.3 EMEA Primary Antibodies Market by Application/End Users
  1.3.1 EMEA Primary Antibodies Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 ELISA
  1.3.3 Western Blot
  1.3.4 Immunostaining
  1.3.5 Immunohistochemistry
  1.3.6 Immunocytochemistry
  1.3.7 Other
1.4 EMEA Primary Antibodies Market by Region
  1.4.1 EMEA Primary Antibodies Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Primary Antibodies (2012-2022)
  1.5.1 EMEA Primary Antibodies Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Primary Antibodies Revenue and Growth Rate (2012-2022)

2 EMEA PRIMARY ANTIBODIES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Primary Antibodies Market Competition by Players/Manufacturers
  2.1.1 EMEA Primary Antibodies Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Primary Antibodies Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Primary Antibodies Sale Price by Players (2012-2017)
2.2 EMEA Primary Antibodies (Volume and Value) by Type/Product Category
  2.2.1 EMEA Primary Antibodies Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Primary Antibodies Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Primary Antibodies Sale Price by Type (2012-2017)
2.3 EMEA Primary Antibodies (Volume) by Application
2.4 EMEA Primary Antibodies (Volume and Value) by Region
  2.4.1 EMEA Primary Antibodies Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Primary Antibodies Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Primary Antibodies Sales Price by Region (2012-2017)

3 EUROPE PRIMARY ANTIBODIES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Primary Antibodies Sales and Value (2012-2017)
  3.1.1 Europe Primary Antibodies Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Primary Antibodies Revenue and Growth Rate (2012-2017)
3.2 Europe Primary Antibodies Sales and Market Share by Type
3.3 Europe Primary Antibodies Sales and Market Share by Application
3.4 Europe Primary Antibodies Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Primary Antibodies Sales Volume by Countries (2012-2017)
  3.4.2 Europe Primary Antibodies Revenue by Countries (2012-2017)
  3.4.3 Germany Primary Antibodies Sales and Growth Rate (2012-2017)
  3.4.4 France Primary Antibodies Sales and Growth Rate (2012-2017)
  3.4.5 UK Primary Antibodies Sales and Growth Rate (2012-2017)
  3.4.6 Russia Primary Antibodies Sales and Growth Rate (2012-2017)
  3.4.7 Italy Primary Antibodies Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Primary Antibodies Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PRIMARY ANTIBODIES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Primary Antibodies Sales and Value (2012-2017)
  4.1.1 Middle East Primary Antibodies Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Primary Antibodies Revenue and Growth Rate (2012-2017)
4.2 Middle East Primary Antibodies Sales and Market Share by Type
4.3 Middle East Primary Antibodies Sales and Market Share by Application
4.4 Middle East Primary Antibodies Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Primary Antibodies Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Primary Antibodies Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Primary Antibodies Sales and Growth Rate (2012-2017)
  4.4.4 Israel Primary Antibodies Sales and Growth Rate (2012-2017)
  4.4.5 UAE Primary Antibodies Sales and Growth Rate (2012-2017)
  4.4.6 Iran Primary Antibodies Sales and Growth Rate (2012-2017)

5 AFRICA PRIMARY ANTIBODIES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Primary Antibodies Sales and Value (2012-2017)
  5.1.1 Africa Primary Antibodies Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Primary Antibodies Revenue and Growth Rate (2012-2017)
5.2 Africa Primary Antibodies Sales and Market Share by Type
5.3 Africa Primary Antibodies Sales and Market Share by Application
5.4 Africa Primary Antibodies Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Primary Antibodies Sales Volume by Countries (2012-2017)
  5.4.2 Africa Primary Antibodies Revenue by Countries (2012-2017)
  5.4.3 South Africa Primary Antibodies Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Primary Antibodies Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Primary Antibodies Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Primary Antibodies Sales and Growth Rate (2012-2017)

6 EMEA PRIMARY ANTIBODIES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Abcam
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Primary Antibodies Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abcam Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 BD
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Primary Antibodies Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 BD Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Santa Cruz Biotechnology
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Primary Antibodies Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Santa Cruz Biotechnology Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sigma Aldrich Corporation
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Primary Antibodies Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sigma Aldrich Corporation Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Thermo Fisher Scientific
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Primary Antibodies Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Thermo Fisher Scientific Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bio-Rad
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Primary Antibodies Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bio-Rad Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 R&D Systems
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Primary Antibodies Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 R&D Systems Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 MBL
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Primary Antibodies Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 MBL Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 CST
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Primary Antibodies Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 CST Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Merk
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Primary Antibodies Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Merk Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Novus Biologicals
6.12 PeproTech
6.13 Cayman
6.14 AbMax Biotechnology
6.15 MABTech
6.16 KPL
6.17 Abnova

7 PRIMARY ANTIBODIES MANUFACTURING COST ANALYSIS

7.1 Primary Antibodies Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Primary Antibodies

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Primary Antibodies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Primary Antibodies Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PRIMARY ANTIBODIES MARKET FORECAST (2017-2022)

11.1 EMEA Primary Antibodies Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Primary Antibodies Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Primary Antibodies Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Primary Antibodies Price and Trend Forecast (2017-2022)
11.2 EMEA Primary Antibodies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Primary Antibodies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Primary Antibodies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Primary Antibodies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Primary Antibodies Sales Forecast by Type (2017-2022)
11.7 EMEA Primary Antibodies Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Primary Antibodies
Figure EMEA Primary Antibodies Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Primary Antibodies Sales Volume Market Share by Type (Product Category) in 2016
Figure Human Product Picture
Figure Animal Product Picture
Figure EMEA Primary Antibodies Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Primary Antibodies by Application in 2016
Figure ELISA Examples
Table Key Downstream Customer in ELISA
Figure Western Blot Examples
Table Key Downstream Customer in Western Blot
Figure Immunostaining Examples
Table Key Downstream Customer in Immunostaining
Figure Immunohistochemistry Examples
Table Key Downstream Customer in Immunohistochemistry
Figure Immunocytochemistry Examples
Table Key Downstream Customer in Immunocytochemistry
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Primary Antibodies Market Size (Million USD) by Region (2012-2022)
Figure Europe Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Primary Antibodies Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Primary Antibodies Revenue (Million USD) Status and Forecast by Countries
Figure Africa Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Primary Antibodies Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Primary Antibodies Sales Volume and Growth Rate (2012-2022)
Figure EMEA Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Primary Antibodies Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Primary Antibodies Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Primary Antibodies Sales Share by Players (2012-2017)
Figure 2016 Primary Antibodies Sales Share by Players
Figure 2017 Primary Antibodies Sales Share by Players
Figure EMEA Primary Antibodies Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Primary Antibodies Revenue (Million USD) by Players (2012-2017)
Table EMEA Primary Antibodies Revenue Share by Players (2012-2017)
Table 2016 EMEA Primary Antibodies Revenue Share by Players
Table 2017 EMEA Primary Antibodies Revenue Share by Players
Table EMEA Primary Antibodies Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Primary Antibodies Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Primary Antibodies Sales Share by Type (2012-2017)
Figure Sales Market Share of Primary Antibodies by Type (2012-2017)
Figure EMEA Primary Antibodies Sales Market Share by Type (2012-2017)
Table EMEA Primary Antibodies Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Primary Antibodies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Primary Antibodies by Type in 2016
Table EMEA Primary Antibodies Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Primary Antibodies Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Primary Antibodies Sales Share by Application (2012-2017)
Figure Sales Market Share of Primary Antibodies by Application (2012-2017)
Figure EMEA Primary Antibodies Sales Market Share by Application in 2016
Table EMEA Primary Antibodies Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Primary Antibodies Sales Share by Region (2012-2017)
Figure Sales Market Share of Primary Antibodies by Region (2012-2017)
Figure EMEA Primary Antibodies Sales Market Share in 2016
Table EMEA Primary Antibodies Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Primary Antibodies Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Primary Antibodies by Region (2012-2017)
Figure EMEA Primary Antibodies Revenue Market Share Regions in 2016
Table EMEA Primary Antibodies Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Primary Antibodies Revenue and Growth Rate (2012-2017)
Table Europe Primary Antibodies Sales (K Pcs) by Type (2012-2017)
Table Europe Primary Antibodies Market Share by Type (2012-2017)
Figure Europe Primary Antibodies Market Share by Type in 2016
Table Europe Primary Antibodies Sales (K Pcs) by Application (2012-2017)
Table Europe Primary Antibodies Market Share by Application (2012-2017)
Figure Europe Primary Antibodies Market Share by Application in 2016
Table Europe Primary Antibodies Sales (K Pcs) by Countries (2012-2017)
Table Europe Primary Antibodies Sales Market Share by Countries (2012-2017)
Figure Europe Primary Antibodies Sales Market Share by Countries (2012-2017)
Figure Europe Primary Antibodies Sales Market Share by Countries in 2016
Table Europe Primary Antibodies Revenue (Million USD) by Countries (2012-2017)
Table Europe Primary Antibodies Revenue Market Share by Countries (2012-2017)
Figure Europe Primary Antibodies Revenue Market Share by Countries (2012-2017)
Figure Europe Primary Antibodies Revenue Market Share by Countries in 2016
Figure Germany Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Primary Antibodies Sales (K Pcs) by Type (2012-2017)
Table Middle East Primary Antibodies Market Share by Type (2012-2017)
Figure Middle East Primary Antibodies Market Share by Type (2012-2017)
Table Middle East Primary Antibodies Sales (K Pcs) by Applications (2012-2017)
Table Middle East Primary Antibodies Market Share by Applications (2012-2017)
Figure Middle East Primary Antibodies Sales Market Share by Application in 2016
Table Middle East Primary Antibodies Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Primary Antibodies Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Primary Antibodies Sales Volume Market Share by Countries in 2016
Table Middle East Primary Antibodies Revenue (Million USD) by Countries (2012-2017)
Table Middle East Primary Antibodies Revenue Market Share by Countries (2012-2017)
Figure Middle East Primary Antibodies Revenue Market Share by Countries (2012-2017)
Figure Middle East Primary Antibodies Revenue Market Share by Countries in 2016
Figure Saudi Arabia Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Primary Antibodies Sales (K Pcs) by Type (2012-2017)
Table Africa Primary Antibodies Sales Market Share by Type (2012-2017)
Figure Africa Primary Antibodies Sales Market Share by Type (2012-2017)
Figure Africa Primary Antibodies Sales Market Share by Type in 2016
Table Africa Primary Antibodies Sales (K Pcs) by Application (2012-2017)
Table Africa Primary Antibodies Sales Market Share by Application (2012-2017)
Figure Africa Primary Antibodies Sales Market Share by Application (2012-2017)
Table Africa Primary Antibodies Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Primary Antibodies Sales Market Share by Countries (2012-2017)
Figure Africa Primary Antibodies Sales Market Share by Countries (2012-2017)
Figure Africa Primary Antibodies Sales Market Share by Countries in 2016
Table Africa Primary Antibodies Revenue (Million USD) by Countries (2012-2017)
Table Africa Primary Antibodies Revenue Market Share by Countries (2012-2017)
Figure Africa Primary Antibodies Revenue Market Share by Countries (2012-2017)
Figure Africa Primary Antibodies Revenue Market Share by Countries in 2016
Figure South Africa Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Table Abcam Primary Antibodies Basic Information List
Table Abcam Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abcam Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abcam Primary Antibodies Sales Market Share in EMEA (2012-2017)
Figure Abcam Primary Antibodies Revenue Market Share in EMEA (2012-2017)
Table BD Primary Antibodies Basic Information List
Table BD Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BD Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure BD Primary Antibodies Sales Market Share in EMEA (2012-2017)
Figure BD Primary Antibodies Revenue Market Share in EMEA (2012-2017)
Table Santa Cruz Biotechnology Primary Antibodies Basic Information List
Table Santa Cruz Biotechnology Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Santa Cruz Biotechnology Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Santa Cruz Biotechnology Primary Antibodies Sales Market Share in EMEA (2012-2017)
Figure Santa Cruz Biotechnology Primary Antibodies Revenue Market Share in EMEA (2012-2017)
Table Sigma Aldrich Corporation Primary Antibodies Basic Information List
Table Sigma Aldrich Corporation Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sigma Aldrich Corporation Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sigma Aldrich Corporation Primary Antibodies Sales Market Share in EMEA (2012-2017)
Figure Sigma Aldrich Corporation Primary Antibodies Revenue Market Share in EMEA (2012-2017)
Table Thermo Fisher Scientific Primary Antibodies Basic Information List
Table Thermo Fisher Scientific Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Primary Antibodies Sales Market Share in EMEA (2012-2017)
Figure Thermo Fisher Scientific Primary Antibodies Revenue Market Share in EMEA (2012-2017)
Table Bio-Rad Primary Antibodies Basic Information List
Table Bio-Rad Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bio-Rad Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bio-Rad Primary Antibodies Sales Market Share in EMEA (2012-2017)
Figure Bio-Rad Primary Antibodies Revenue Market Share in EMEA (2012-2017)
Table R&D Systems Primary Antibodies Basic Information List
Table R&D Systems Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure R&D Systems Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure R&D Systems Primary Antibodies Sales Market Share in EMEA (2012-2017)
Figure R&D Systems Primary Antibodies Revenue Market Share in EMEA (2012-2017)
Table MBL Primary Antibodies Basic Information List
Table MBL Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MBL Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure MBL Primary Antibodies Sales Market Share in EMEA (2012-2017)
Figure MBL Primary Antibodies Revenue Market Share in EMEA (2012-2017)
Table CST Primary Antibodies Basic Information List
Table CST Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CST Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure CST Primary Antibodies Sales Market Share in EMEA (2012-2017)
Figure CST Primary Antibodies Revenue Market Share in EMEA (2012-2017)
Table Merk Primary Antibodies Basic Information List
Table Merk Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merk Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merk Primary Antibodies Sales Market Share in EMEA (2012-2017)
Figure Merk Primary Antibodies Revenue Market Share in EMEA (2012-2017)
Table Novus Biologicals Primary Antibodies Basic Information List
Table PeproTech Primary Antibodies Basic Information List
Table Cayman Primary Antibodies Basic Information List
Table AbMax Biotechnology Primary Antibodies Basic Information List
Table MABTech Primary Antibodies Basic Information List
Table KPL Primary Antibodies Basic Information List
Table Abnova Primary Antibodies Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Primary Antibodies
Figure Manufacturing Process Analysis of Primary Antibodies
Figure Primary Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Primary Antibodies Major Manufacturers in 2016
Table Major Buyers of Primary Antibodies
Table Distributors/Traders List
Figure EMEA Primary Antibodies Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Primary Antibodies Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Primary Antibodies Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Primary Antibodies Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Primary Antibodies Sales Market Share Forecast by Region (2017-2022)
Table EMEA Primary Antibodies Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Primary Antibodies Revenue Market Share Forecast by Region (2017-2022)
Table Europe Primary Antibodies Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Primary Antibodies Sales Market Share Forecast by Countries (2017-2022)
Table Europe Primary Antibodies Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Primary Antibodies Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Primary Antibodies Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Primary Antibodies Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Primary Antibodies Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Primary Antibodies Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Primary Antibodies Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Primary Antibodies Sales Market Share Forecast by Countries (2017-2022)
Table Africa Primary Antibodies Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Primary Antibodies Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Primary Antibodies Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Primary Antibodies Sales Market Share Forecast by Type (2017-2022)
Table EMEA Primary Antibodies Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Primary Antibodies Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources